These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 9324221)

  • 21. Global eradication of poliomyelitis: reinvent the wheel or use existing options effectively?
    Ogra PL
    Public Health Rev; 1993-1994; 21(1-2):143-50. PubMed ID: 8041881
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunogenicity, safety, and antibody persistence at 3, 5, and 10 years postvaccination in adolescents randomized to booster immunization with a combined tetanus, diphtheria, 5-component acellular pertussis, and inactivated poliomyelitis vaccine administered with a hepatitis B virus vaccine concurrently or 1 month apart.
    Embree J; Law B; Voloshen T; Tomovici A
    Clin Vaccine Immunol; 2015 Mar; 22(3):282-90. PubMed ID: 25540274
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunity to poliomyelitis: situation in northern Italy and in some other European population groups.
    Pianetti A; Biffi MR; Rocchi MB; Bruscolini F; Salvaggio L; Albano A
    Infection; 2002 Aug; 30(4):213-5. PubMed ID: 12236564
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunity to poliomyelitis in The Netherlands.
    Conyn-Van Spaendonck MA; de Melker HE; Abbink F; Elzinga-Gholizadea N; Kimman TG; van Loon T
    Am J Epidemiol; 2001 Feb; 153(3):207-14. PubMed ID: 11157405
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antipolio prophylaxis of immunocompromised children during a nationwide oral poliovaccine campaign.
    Stenvik M; Hovi L; Siimes MA; Roivainen M; Hovi T
    Pediatr Infect Dis J; 1987 Dec; 6(12):1106-10. PubMed ID: 2829105
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Re: Immunity against poliomyelitis in refugees in Italy.
    Tafuri S; Prato R
    J Travel Med; 2010; 17(5):360-1. PubMed ID: 20920062
    [No Abstract]   [Full Text] [Related]  

  • 27. Prevalence of anti-poliovirus type 1, 2 and 3 antibodies in unvaccinated Italian travelers.
    Signorini L; Barbi M; Matteelli A; Binda S; Didò P; Caroppo S; Primache V; Pisani S; Messino C; Brunelli M; Costa P; Ronca E; Fausti C; Castelli F
    J Travel Med; 2004; 11(1):34-6. PubMed ID: 14769285
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A seroepidemiologic survey of immunity against poliomyelitis in a group of HIV positive and HIV negative drug addicts.
    Pregliasco F; Minolfi V; Boschin A; Andreassi A; Profeta ML
    Eur J Epidemiol; 1995 Dec; 11(6):693-5. PubMed ID: 8861854
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Status of herd immunity to poliomyelitis in children in the Moscow region].
    Seĭbil' VB; Voroshilova MK; Boĭko VM; Troshina LD
    Vopr Virusol; 1975; (1):87-91. PubMed ID: 123674
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence of poliovirus neutralizing antibodies. A seroepidemiologic survey of vaccinated and unvaccinated women of fertile age.
    Moschen ME; Farisano G; Bonello C; Benussi G; Barbone F; Gasparini V; Trivello R
    Boll Ist Sieroter Milan; 1987; 66(2):97-100. PubMed ID: 2822063
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Poliomyelitis immunity status in the centro-meridional Italy].
    Ribera G; Angelillo IF; Ricciardi G; Grasso GM; Villari P
    Ann Ig; 1995; 7(6):421-9. PubMed ID: 8663971
    [No Abstract]   [Full Text] [Related]  

  • 32. Poliovirus-specific memory immunity in seronegative elderly people does not protect against virus excretion.
    Abbink F; Buisman AM; Doornbos G; Woldman J; Kimman TG; Conyn-van Spaendonck MA
    J Infect Dis; 2005 Mar; 191(6):990-9. PubMed ID: 15717277
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Experiences with polio vaccination and herd immunity in Finland.
    Lapinleimu K; Stenvik M
    Dev Biol Stand; 1981; 47():241-6. PubMed ID: 6262149
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Decision analysis in planning for a polio outbreak in the United States.
    Jenkins PC; Modlin JF
    Pediatrics; 2006 Aug; 118(2):611-8. PubMed ID: 16882814
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Herd immunity against poliomyelitis in children in the Moscow Region].
    Seĭbil' VB; Malyshkina LP; Tamazian GV; Konopleva TN; Uspenskaia ES
    Vopr Virusol; 2009; 54(6):13-8. PubMed ID: 20030276
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Cluster of Paralytic Poliomyelitis Cases Due to Transmission of Slightly Diverged Sabin 2 Vaccine Poliovirus.
    Korotkova EA; Gmyl AP; Yakovenko ML; Ivanova OE; Eremeeva TP; Kozlovskaya LI; Shakaryan AK; Lipskaya GY; Parshina IL; Loginovskikh NV; Morozova NS; Agol VI
    J Virol; 2016 Jul; 90(13):5978-88. PubMed ID: 27099315
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Artificial herd immunity to poliomyelitis in a semirural community in South Africa.
    Winter PA; Krynauw JD; Marais GA
    S Afr Med J; 1981 Dec; 60(23):889-90. PubMed ID: 6272430
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Poliomyelitis outbreak in Israel in 1988: a report with two commentaries.
    Slater PE; Orenstein WA; Morag A; Avni A; Handsher R; Green MS; Costin C; Yarrow A; Rishpon S; Havkin O
    Lancet; 1990 May; 335(8699):1192-5; discussion 1196-8. PubMed ID: 1971043
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Enhancing the immunogenicity of inactivated polio vaccines with chitosan used as an adjuvant].
    Gendon IuZ; Markushin SG; Akopova II; Krivtsov GG; Akhmatova NK; Koptiaeva IB; Vasil'ev IuM
    Vopr Virusol; 2011; 56(6):28-32. PubMed ID: 22359946
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Antipoliomyelitis vaccination of young children with a new inactivated vaccine. Serological results].
    Grenier B; Viarme F; Roumiantzeff M; Xueref C; Demont F
    Arch Fr Pediatr; 1985 Apr; 42(4):321-3. PubMed ID: 4004496
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.